Skip to main content

Ardent Health, Inc. (ARDT) Stock Analysis

Range Bound setup

SellModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $9.80: Risk below floor (2.1 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 1.69; Negative price momentum; Below long-term trend.

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services,... Read more

$9.80+11.0% A.UpsideScore 5.8/10#8 of 27 Medical Care Facilities
QualityF-score8 / 9FCF yield8.01%
Stop $9.11Target $10.88(analyst − 13%)A.R:R 1.0:1
Analyst target$12.50+27.6%11 analysts
$10.88our TP
$9.80price
$12.50mean
$14

Sell if holding. Engine safety override at $9.80: Risk below floor (2.1 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 1.69; Negative price momentum; Below long-term trend. Chart setup: RSI 52 mid-range, Bollinger mid-band. Score 5.8/10, moderate confidence.

Passes 5/8 gates (clean insider activity, no SEC red flags, earnings proximity 84d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.

Recent Developments — Ardent Health, Inc.

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
No bull case signals
Risks
Risk below floor (2.1 < 3.0)

Key Metrics

P/E (TTM)10.7
P/E (Fwd)7.7
Mkt Cap$1.5B
EV/EBITDA7.0
Profit Mgn2.1%
ROE13.9%
Rev Growth7.0%
Beta
DividendNone
Rating analysts18

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.69bearish
IV92%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Volatile — 5.4% daily ATR makes tight stops impractical. Position-size conservatively.static

Volatility
0.0
Implied Vol
0.0
Days To Cover
0.9
Put Call
2.1
Debt Equity
4.4
Short Interest
5.3
Elevated put/call: 1.69High IV: 92%

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
3.0
Macd
3.5
Volume
3.6
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope -3.6%/30d — confirmed downtrend
GatesMomentum 3.1<4.5A.R:R 1.0 < 1.5@spotDeath cross (50MA < 200MA)Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 84d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
52 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $9.11Resistance $10.40

Price Targets

$9
$11
A.Upside+11.0%
A.R:R1.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Risk below floor (2.1 < 3.0)
! Momentum score 3.1/10 — below 4.5 minimum
! Reward/Risk 1.0:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-11 (84d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ARDT stock a buy right now?

Sell if holding. Engine safety override at $9.80: Risk below floor (2.1 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 1.69; Negative price momentum; Below long-term trend. Chart setup: RSI 52 mid-range, Bollinger mid-band. Prior stop was $9.11. Score 5.8/10, moderate confidence.

What is the ARDT stock price target?

Take-profit target: $10.88 (+11.0% upside). Prior stop was $9.11. Stop-loss: $9.11.

What are the risks of investing in ARDT?

Risk below floor (2.1 < 3.0).

Is ARDT overvalued or undervalued?

Ardent Health, Inc. trades at a P/E of 10.7 (forward 7.7). TrendMatrix value score: 8.7/10. Verdict: Sell.

What do analysts say about ARDT?

18 analysts cover ARDT with a consensus score of 3.9/5. Average price target: $13.

What does Ardent Health, Inc. do?Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the...

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent) · UHS (Universal Health Services, Inc.) · EHC (Encompass Health Corporation)